June 5, 2025 | Patient involvement, Trial Design, clinical trials, insight, patient engagement
Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Cuttsy+Cuttsy, the original patient communications agency, in partnership with the International Society for Patient Engagement Professionals (ISPEP), is proud to announce the upcoming release of their latest report, offering a 360-degree view into patient engagement in clinical trials, both at recruitment stage and during their time participating in a trial.
Based on extensive global research with over 700 clinical trial patients, as well as insights from the specialist Cuttsy+Cuttsy team alongside industry leaders, the report provides a comprehensive analysis of patient experiences. It sheds light on their motivations, emotional and psychological responses, effectiveness of support materials, and need for clear communication during clinical trials. By gathering feedback from an international audience, the findings offer actionable strategies to enhance patient satisfaction, trial completion rates, and overall study success on a global stage.
“Too often, the patient voice is acknowledged in theory but overlooked in practice,” said Caroline Benson, Co-Founder of Cuttsy+Cuttsy. “This report is about more than metrics; it’s about truly listening to what patients experience and need. When we design trials around real people, not just protocols, everyone wins.”
Alongside ISPEP’s aim to amplify the patient voice across medicine development, this report exemplifies Cuttsy+Cuttsy’s mission to empower the healthcare industry with data-driven tools that advance patient-centric approaches to clinical research.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
